Target-Based Antimicrobial Drug Discovery - Bacterial Pathogenesis: Methods and Protocols - page 265

15. Georgopapadakou, N. H. (2004) Beta-lactamase inhibitors: evolving compounds
for evolving resistance targets. Expert Opin. Investig. Drugs 13 , 1307-1318.
16. Rogers, B. L. (2004) Bacterial targets to antimicrobial leads and development
candidates. Curr. Opin. Drug Discov. Dev . 7 , 211-222.
17. Halliday, J., McKeveney, D., Muldoon, C., Rajaratnam, P. and Meutermans, W.
(2006) Targeting the forgotten transglycosylases. Biochem. Pharmacol . 71 , 957-967.
18. Silver, L. L. (2003) Novel inhibitors of bacterial cell wall synthesis. Curr. Opin.
Microbiol . 6 , 431-438.
19. Sutcliffe, J. A. (2005). Improving on nature: antibiotics that target the ribosome.
Curr. Opin. Microbiol . 8 , 534-542.
20. Alksne, L. E., Anthony, R. A., Liebman, S. W., and Warner, J. R. (1993). An
accuracy center in the ribosome conserved over 2 billion years. Proc. Natl. Acad.
Sci. U.S.A . 90 , 9538-9541.
21. Franceschi, F. and Duffy, E. M. (2006) Structure-based drug design meets the
ribosome. Biochem. Pharmacol . 71 , 1016-1025.
22. Ebright, R. H. (2000) RNA polymerase: structural similarities between bacterial
RNA polymerase and eukaryotic RNA polymerase II. J. Mol. Biol . 304 , 687-98.
23. Bruck, I. and O'Donnell, M. (2000) The DNA replication machine of a gram-
positive organism. J. Biol. Chem . 275 , 28971-28983.
24. Bermingham, A. and Derrick, J. P. (2002) The folic acid biosynthesis pathway
in bacteria: evaluation of potential for antibacterial drug discovery. Bioessays 24 ,
637-648.
25. Heath, R. J., White, S. W., and Rock, C. O. (2002) Inhibitors of fatty acid synthesis
as antimicrobial chemotherapeutics. Appl. Microbiol. Biotechnol . 58 , 695-703.
26. Zhao, L., Allanson, N. M., Thomson, S. P., Maclean, J. K., Barker, J. J., Primrose,
W. U., Tyler, P. D., and Lewendon, A. (2003) Inhibitors of phosphopantetheine
adenylyltransferase. Eur. J. Med. Chem . 38 , 345-349.
27. Hutton, C. A., Southwood, T. J., and Turner, J. J. (2003) Inhibitors of lysine
biosynthesis as antibacterial agents. Mini Rev. Med. Chem . 3 , 115-127.
28. Gunderson, C. W. and Segall, A. M. (2006) DNA repair, a novel antibacterial
target: Holliday junction-trapping peptides induce DNA damage and chromosome
segregation defects. Mol. Microbiol . 59 , 1129-1148.
29. Pohlmann, J. and Brotz-Oesterhelt, H. (2004) New aminoacyl-tRNA synthetase
inhibitors as antibacterial agents. Curr. Drug Targets Infect. Disord . 4 , 261-272.
30. Clements, J. M., Ayscough, A. P., Keavey, K., and East, S. P. (2002) Peptide
deformylase inhibitors, potential for a new class of broad spectrum antibacterials.
Curr. Med. Chem. Antiinfect. Agents 1 , 239-249.
31. Johnson, K. W., Lofland, D., and Moser, H. E. (2005) PDF inhibitors: an emerging
class of antibacterial drugs. Curr. Drug Targets Infect. Disord . 5 , 39-52.
32. Leeds, J. A., Schmitt, E. K., and Krastel, P. (2006) Recent developments in
antibacterial drug discovery: microbe-derived natural products-from collection to
the clinic. Expert Opin. Investig. Drugs 15 , 211-226.